2024 Ionis Pharmaceuticals First Half Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-?-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
Sanofi Nine Months 2021 Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
October 2021
-
2021 Abbvie Mid-Year Review-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
US$ 750.00
June 2021
-
2019 Pharmaceutical Competitive Intelligence: Allergan Performance, Capabilities, Goals and Strategies
US$ 950.00
February 2019
-
2018 Leading Animal Health Companies: Strategies, Marketing Tactics, Technological Know-How and Global Sales Segment Forecasts
US$ 4,850.00
September 2018
110 pages
2021 Mallinckrodt SWOT Analysis-Performance, Capabilities, Goals and Strategies
US$ 750.00
January 2021
-
